The time is right to look at new ways of reducing mortality among people who use illicit drugs. Across the UK, we are seeing record levels of drug-related deaths. These deaths often occur among people who use heroin, as well as alcohol and tobacco. The appearance of synthetic opioids like fentanyl and carfentanil in the UK drug markets threatens to cause even more harm.Many of the most vulnerable people are not well served by existing models of treatment. So we need new ways of engaging these people in services that can save their lives. The need for drug consumption rooms is urgent.
Safer drug consumption facilities (SDCFs) are clean, hygienic environments where people can consume drugs, obtained elsewhere, under the supervision of trained health professionals.
Harm Reduction Coalition invited experts from several countries to share their various SIF models, planning and policy development process, implementation challenges, and evaluation results. This report is a summary of the proceedings of the consultation.
This resource is intended for harm reduction service providers with limited experience of working with children and young people who inject drugs. It sets out a process that you can go through quickly, with little cost, to prepare for work with children and young people who are under 18.
Preventing the transmission of blood-borne viruses (BBV) such as HIV, hepatitis B and hepatitis C among people who inject drugs can have wide-reaching benefits: reducing health harms to individuals and subsequent costs to society.
This annual national report describes trends in the extent of infections and associated risks and behaviours among people who inject drugs in the UK to the end of 2016. This information is essential to understanding the extent of these infections, the risk factors for their acquisition, and for monitoring the effectiveness of prevention measures.
Supervised drug consumption facilities, where illicit drugs can be used under the supervision of trained staff, have been operating in Europe for the last three decades.
This annual national report describes trends in the extent of infections and associated risks and behaviours among people who inject drugs in the UK to the end of 2014. This information is essential to understanding the extent of these infections, the risk factors for their acquisition, and for monitoring the effectiveness of prevention measures.
The uk government has released the details of the changes being made in UK law to ease distribution of naloxone to people who are at risk of opiate overdose (changes will be happening Oct 2015).